Markets
Money ring surrounding earth
(Getty Images)

Fund managers are worried about AI overinvestment. Bank of America is worried about fund managers overinvesting.

For the first time ever, fund managers surveyed by Bank of America think companies are investing too much.

Luke Kawa

For the first time ever, fund managers surveyed by Bank of America think companies are investing too much.

“Bad news…1st time in 20 years investors say companies ‘overinvesting’ (read ‘slow down, hyperscalers’),” Chief Investment Strategist Michael Hartnett wrote, commenting on the results of BofA’s monthly fund manager survey. “Asked about the biggest ‘tail risk’ for the economy and the markets, 45% of FMS investors said ‘AI bubble’ (up from 33% last month).”

BofA capex overinvesting

Now, what this really shows, as Hartnett alludes to, is a very concentrated industry-specific concern around the aggressiveness of the AI build-out. Over on Bluesky, Bespoke analyst George Pearkes flagged that net private investment as a share of US GDP has effectively been a flat line for years.

“Just shows how tech-centric investors are. AI of course might be over-investing but the non-tech economy is stagnating or in recession and definitely isn’t overinvesting,” added Conor Sen, founder of Peachtree Creek Investments. “Office construction is weak, residential construction is weak, the freight industry is in recession, autos are pulling back on some EV spending.”

Fund managers would prefer that companies improve their balance sheets or return more cash to shareholders rather than boost business investment. That would certainly be a shift in what’s been rewarded in the stock market.

Year to date, a basket of the most capex-intensive stocks in the S&P 500 compiled by Goldman Sachs is up over 21%, outperforming baskets of companies with strong balance sheets and high shareholder returns by about 14 and 5 percentage points, respectively. Firms with high levels of investments have also bested these other cohorts over the past one and three months.

The irony about this survey is that while it says fund managers purport to be worried about overinvestment, if anything, BofA suggests that the overinvestment they should be worried about is their own: average cash levels among those surveyed dipped to 3.7% from 3.8%.

“Note cash levels of 3.7% or lower has occurred 20 times since 2002, and on every occasion stocks fell and Treasuries outperformed in the following 1-3 months,” says Hartnett, who called this low level of dry powder a “sell signal.”

BofA cash levels

More Markets

See all Markets
markets

Strategy jumps as MSCI allows digital asset treasury companies to stay in global indexes

In a massive reprieve for Strategy, index provider MSCI is letting digital asset companies stay in its benchmarks, sending shares sharply higher in after-hours trading.

The index provider had floated a proposal in which firms where crypto holdings are more than 50% of assets would be excluded from its global indexes, but has decided not to proceed with this for now.

“MSCI has determined at this time not to implement the proposal to exclude digital asset treasury companies (‘DATCOs’) from the MSCI Global Investable Market Indexes (‘MSCI Indexes’) as part of the February 2026 Index Review,” per a statement.

Getting kicked out of key indexes would have caused funds to flow out of Strategy, the largest digital asset treasury company, and its peers.

“At this time,” of course, means the door is open to reconsidering this down the road, as MSCI plans on having a broader review and consultation on the treatment of DAT companies.

“Distinguishing between investment companies and other companies that hold non-operating assets, such as digital assets, as part of their core operations rather than for investment purposes requires further research and consultation with market participants,” according to MSCI.

markets

Rocket Lab surges to second straight record-high close

Retail favorite Rocket Lab closed at a new all-time high on Tuesday, continuing a remarkable run over the last month that has carried the launch services provider and aspiring Space X competitor up more than 70% over the last month (compared to its close of $49.06 on December 5).

Rocket Lab saw elevated options activity during its run-up today, with well over 3.5x the 90-day average in options volume changing hands over the course of the day.

Other space plays such as AST SpaceMobile and EchoStar surged today.

Despite being a money-losing company — it’s never turned an annual profit as a public company — Rocket Lab’s share price has soared nearly 1,500% over the last two years, generating tons of loyalty and enthusiasm among retail investors.

In fact, Goldman Sachs has made Rocket Lab the heaviest weighting in the latest iteration of its GS Memes basket of thematic stocks, just ahead of AST SpaceMobile, showing how enamored traders have become of such space stocks.

CHICAGO, IL - MARCH 05: Benny, the mascot for the Chicago Bulls entertains during a break between the Bulls and the Boston Celtics at the United Center on March 5, 2018 in Chicago, Illinois.

The S&P 500 closes at a record high

The Nasdaq 100 and Russell 2000 outperformed, rising 0.9% and 1.4%, respectively.

markets

JetBlue takes off on bullish options activity

Low-cost airline JetBlue is up more than 8% on Tuesday, on pace for its biggest daily gain since August. If the price momentum holds, Tuesday will mark JetBlue’s sixth-best trading day of the past 52 weeks.

The carrier is being propelled by bullish options activity, with more than 53,000 call options changing hands as of 12:14 p.m. ET, nearly 4x the 20-day average for a full session.

JetBlue closed up 4.6% on Monday, as traders appeared to price in medium-term oil supply relief due to the possibility of Venezuela’s reserves getting more developed amid tensions with the US.

markets

Moderna rallies after BofA raises its price target to $24 from $21

Moderna rose on Tuesday after Bank of America analysts raised their price target for the ailing biotech behind the COVID-19 vaccine, painting a rosy picture of the products in its pipeline.

BofA kept Moderna’s “underperform” rating but raised its price target to $24 from $21, which now accounts for “refreshed revenue builds for lead assets.” Analysts said the company’s cost-cutting measures, paired with potential new revenue from its investigatory oncology vaccines, could bring it back to profitability in the coming years.

Moderna is best known for being tapped by the US government to quickly develop a vaccine for COVID-19 in 2020, a product that remains its single source of revenue. The company has yet to bring new products to market and is now faced with a second Trump administration hostile to that product.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.